Clinical trial shows positive results for potential treatment to combat a challenging rare disease

  • Post author:
  • Post category:uncategorized

Researchers have demonstrated that inebilizumab reduced the risk of symptoms by 87 percent in patients with the rare affliction known as immunoglobulin G4-related disease (IgG4-RD).